Our answer is supporting patients and improving the quality of life of those patients every day. Sergio Cantoreggi PhD, Head R&D at Helsinn at down with PSI to discuss how our relationship of more than 15 years has prompted the development of oncologic therapies that help improve patient outcomes and quality of life.